NM_152618.3:c.270delT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_152618.3(BBS12):c.270delT(p.Val92LeufsTer20) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000342 in 1,461,674 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. F90F) has been classified as Likely benign.
Frequency
Consequence
NM_152618.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 12Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, Myriad Women’s Health
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BBS12 | NM_152618.3 | c.270delT | p.Val92LeufsTer20 | frameshift_variant | Exon 2 of 2 | ENST00000314218.8 | NP_689831.2 | |
| BBS12 | NM_001178007.2 | c.270delT | p.Val92LeufsTer20 | frameshift_variant | Exon 3 of 3 | NP_001171478.1 | ||
| BBS12 | XM_011531680.3 | c.270delT | p.Val92LeufsTer20 | frameshift_variant | Exon 2 of 2 | XP_011529982.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BBS12 | ENST00000314218.8 | c.270delT | p.Val92LeufsTer20 | frameshift_variant | Exon 2 of 2 | 1 | NM_152618.3 | ENSP00000319062.3 | ||
| BBS12 | ENST00000542236.5 | c.270delT | p.Val92LeufsTer20 | frameshift_variant | Exon 3 of 3 | 2 | ENSP00000438273.1 | |||
| BBS12 | ENST00000433287.1 | c.270delT | p.Val92LeufsTer20 | frameshift_variant | Exon 3 of 3 | 2 | ENSP00000398912.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000400 AC: 1AN: 250296 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461674Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727112 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 12 Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
Bardet-Biedl syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Val92Leufs*20) in the BBS12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 619 amino acid(s) of the BBS12 protein. This variant is present in population databases (no rsID available, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Bardet-Biedl syndrome (PMID: 17160889). This variant is also known as 268delT. ClinVar contains an entry for this variant (Variation ID: 555873). This variant disrupts a region of the BBS12 protein in which other variant(s) (p.Asp687Valfs*3) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at